Clinical Trial Update: A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) [Phase 1]

View source ↗

Summary

A Phase 1 study of selumetinib in Chinese pediatric and adult subjects with Neurofibromatosis Type 1 and inoperable plexiform neurofibromas is ongoing, with sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Koselugo (selumetinib)

Snippet

Sponsor: AstraZeneca | Conditions: Neurofibromatosis 1, Neurofibroma Plexiform | Phase 1 | Status: ACTIVE_NOT_RECRUITING